{"news_desk": "SundayBusiness", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "Andrew Pollack, Katie Benner and Doris Burke contributed reporting.", "original": "By REED ABELSON and JULIE CRESWELL", "person": [{"rank": 1, "role": "reported", "firstname": "Reed", "organization": "", "lastname": "ABELSON"}, {"rank": 2, "role": "reported", "firstname": "Julie", "organization": "", "lastname": "CRESWELL"}]}, "abstract": "Theranos founder and chief executive Elizabeth Holmes is attempting to rescue reputation of company and its blood testing technology; Food and Drug Administration is requiring equipment and tests to submit to regulatory process for approval; Holmes' challenge is to convince FDA and consumers of products' efficacy.", "type_of_material": "News", "word_count": "2876", "lead_paragraph": "Elizabeth Holmes built Theranos into a company valued at $9 billion, with help from some powerful family connections, but its successes have been fleeting.", "pub_date": "2015-12-20T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Theranos Founder Faces a Test of Technology, and Reputation", "print_headline": "Theranos Founder Faces Ultimate Test of Mission"}, "snippet": "Elizabeth Holmes built Theranos into a company valued at $9 billion, with help from some powerful family connections, but its successes have been fleeting.", "multimedia": [{"height": 126, "url": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbWide-v2.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbWide-v2.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 1056, "url": "images/2015/12/20/business/20THERANOS/20THERANOS-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "1056", "xlarge": "images/2015/12/20/business/20THERANOS/20THERANOS-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/20/business/theranos-founder-faces-a-test-of-technology-and-reputation.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Theranos Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Holmes, Elizabeth (1984- )", "name": "persons"}, {"rank": "3", "is_major": "Y", "value": "Tests (Medical)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Blood", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Venture Capital", "name": "subject"}], "blog": [], "_id": "5675914c38f0d82604f362ea", "source": "The New York Times"}